» Articles » PMID: 34204094

Deciphering the Long Non-Coding RNAs and MicroRNAs Coregulation Networks in Ovarian Cancer Development: An Overview

Overview
Journal Cells
Publisher MDPI
Date 2021 Jul 2
PMID 34204094
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Non-coding RNAs are emergent elements from the genome, which do not encode for proteins but have relevant cellular functions impacting almost all the physiological processes occurring in eukaryotic cells. In particular, microRNAs and long non-coding RNAs (lncRNAs) are a new class of small RNAs transcribed from the genome, which modulate the expression of specific genes at transcriptional and posttranscriptional levels, thus adding a new regulatory layer in the flux of genetic information. In cancer cells, the miRNAs and lncRNAs interactions with its target genes and functional pathways are deregulated as a consequence of epigenetic and genetic alterations occurring during tumorigenesis. In this review, we summarize the actual knowledge on the interplay of lncRNAs with its cognate miRNAs and mRNAs pairs, which interact in coregulatory networks with a particular emphasis on the mechanisms underlying its oncogenic behavior in ovarian cancer. Specifically, we reviewed here the evidences unraveling the relevant roles of lncRNAs/miRNAs pairs in altered regulation of cell migration, angiogenesis, therapy resistance, and Warburg effect. Finally, we also discussed its potential clinical implications in ovarian cancer and related endocrine disease therapies.

Citing Articles

Exploring the ceRNA network involving AGAP2-AS1 as a novel biomarker for preeclampsia.

Lu F, Zeng N, Xiao X, Wang X, Gong H, Lei H Sci Rep. 2024; 14(1):27330.

PMID: 39521940 PMC: 11550820. DOI: 10.1038/s41598-024-79224-2.


Exploring the nexus between MYH9 and tumors: novel insights and new therapeutic opportunities.

Gou Z, Zhang D, Cao H, Li Y, Li Y, Zhao Z Front Cell Dev Biol. 2024; 12:1421763.

PMID: 39149512 PMC: 11325155. DOI: 10.3389/fcell.2024.1421763.


Abnormal expressions of PURPL, miR-363-3p and ADAM10 predicted poor prognosis for patients with ovarian serous cystadenocarcinoma.

Zhang R, Guo X, Zhao L, He T, Feng W, Ren S J Cancer. 2023; 14(15):2908-2918.

PMID: 37781085 PMC: 10539555. DOI: 10.7150/jca.87405.


The Enticing Path of miR Therapeutics: Difficult but Not without Prospects.

Vikram A Cells. 2022; 11(3).

PMID: 35159228 PMC: 8833969. DOI: 10.3390/cells11030418.


The Role of Long Non-Coding RNAs (lncRNAs) in Female Oriented Cancers.

Naz F, Tariq I, Ali S, Somaida A, Preis E, Bakowsky U Cancers (Basel). 2021; 13(23).

PMID: 34885213 PMC: 8656502. DOI: 10.3390/cancers13236102.

References
1.
Yoon J, Abdelmohsen K, Gorospe M . Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol. 2012; 425(19):3723-30. PMC: 3594629. DOI: 10.1016/j.jmb.2012.11.024. View

2.
Zhang X, Liu T, Li Y, Li S . Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer. Int J Clin Exp Pathol. 2015; 8(8):9440-5. PMC: 4583933. View

3.
Wang J, Ye C, Liu J, Hu Y . UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis. Biochem Biophys Res Commun. 2018; 501(4):1034-1040. DOI: 10.1016/j.bbrc.2018.05.104. View

4.
Zhang J, Liu J, Xu X, Li L . Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer. Cancer Chemother Pharmacol. 2017; 79(3):479-487. DOI: 10.1007/s00280-017-3238-4. View

5.
Liu H, Chen R, Kang F, Lai H, Wang Y . KCNQ1OT1 promotes ovarian cancer progression via modulating MIR-142-5p/CAPN10 axis. Mol Genet Genomic Med. 2020; 8(2):e1077. PMC: 7005641. DOI: 10.1002/mgg3.1077. View